Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GRAL market cap is 1.03B. The company's latest EPS is USD -43.2416 and P/E is -0.70.
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Revenue | 93.11M |
| Operating Income | -1.52B |
| Net Income | -1.47B |
| Year End 31 December 2023 | 2023 |
|---|---|
| USD (US$) | |
| Total Assets | 3.91B |
| Total Liabilities | 267.63M |
| Total Equity | 3.65B |
| Market Cap | 1.03B |
| Price to Earnings Ratio | -0.70 |
| Price to Sales Ratio | 11.03 |
| Price to Cash Ratio | 10.55 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 33.9M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 1.61M |
| 52 Week Change | 63.45% |
| 52 Week High | 63.99 |
| 52 Week Low | 12.33 |
| Spread (Intraday) | 0.29 (0.95%) |
| Company Name | GRAIL Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://grail.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
